echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimer Dementia-Immune disorders are associated with early cognitive decline

    Alzheimer Dementia-Immune disorders are associated with early cognitive decline

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Genome-wide association studies ( GWAS ), Alzheimer's disease (AD) animal models, and neuropathological studies jointly support the central role of immune disorders in AD and cognitive decline in later life
    .


    However, when and how the immune system contributes to the decades-long human AD pathogenesis is still largely unknown, and it is also known whether an increase or decrease in the activity of various immune pathways can predict the progression of AD.


    GWAS immunization

    Although cerebrospinal fluid (CSF) markers of neuroinflammation reflect the progress of AD, CSF sampling requires invasive lumbar puncture and is difficult to promote and implement in large multicenter clinical trials
    .


    On the other hand, blood-based biomarker measurement is less invasive and therefore easier to evaluate in clinical trials and clinical practice


    However, the longitudinal relationship between plasma cytokines and AD biomarkers and the future cognitive decline rate of CU elderly is still poorly understood


    They measured 9 cytokines in the baseline plasma of 298 long-term follow-up CU elderly people, and assessed whether these measures were related to cognitive decline, alone or synergistically with Aβ
    .


    They next studied the association between cytokine levels and neuroimaging biomarkers of Aβ/tau/neurodegeneration


    They found that in the case of higher Aβ, higher IL-12p70 was associated with slower cognitive decline, and higher IFN-γ was associated with slower cognitive decline, not with Aβ (FDR=0.
    013)
    .

    Higher IL-12p70 is associated with slower cognitive decline, while higher IFN-γ is associated with slower cognitive decline, and has nothing to do with Aβ (FDR=0.
    013)
    .


    Higher IL-12p70 is associated with slower cognitive decline, and higher IFN-γ is associated with slower cognitive decline, and has nothing to do with Aβ (FDR=0.


    Among participants with higher Aβ, higher IL-12p70 was associated with less tau and neurodegeneration



    Original source:
    Yang HS, Zhang C, Carlyle BC, Zhen SY, Trombetta BA, Schultz AP, Pruzin JJ, Fitzpatrick CD, Yau WW, Kirn DR, Rentz DM, Arnold SE, Johnson KA, Sperling RA, Chhatwal JP, Tanzi RE .


    Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults.
    Alzheimers Dement.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.